Position in NVS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$27,854,879
+$25,651,450 QoQ
Shares Held
182,356
+681.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 96.31709403584198.ToString("F0")%
Shared 0.ToString("F0")%
None 3.6829059641580204.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FERGUSON WELLMAN CAPITAL MANAGEMENT, INC holds $467,957,783 across 9 Drug Manufacturers - General names. NVS ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
650,411 | $141,457,887 | |
| 2 | JNJ |
Johnson & Johnson
|
469,028 | $114,649,203 | |
| 3 | AMGN |
Amgen Inc
|
319,238 | $112,323,890 | |
| 4 | MRK |
Merck & Co., Inc.
|
385,956 | $46,426,647 | |
| 5 | NVS |
Novartis AG
This page
|
182,356 | $27,854,879 | |
| 6 | LLY |
ELI LILLY & Co
|
21,116 | $19,421,862 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
46,278 | $2,806,760 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
15,327 | $2,136,123 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,854,879 | 182,356 | Shares | Sole | 2026-05-01 | |
| 2020-12-31 | $2,203,429 | 23,334 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,029,124 | 23,334 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,043,231 | 23,394 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,928,835 | 23,394 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||